Rivaroxaban API: Factor Xa Inhibitor for Anticoagulation
Rivaroxaban is a direct oral factor Xa inhibitor used for prevention and treatment of thromboembolic events. Learn about its API characteristics for formulation.
Overview of Rivaroxaban API
Rivaroxaban is an oral direct factor Xa inhibitor used as an anticoagulant in the prevention and treatment of venous thromboembolism and to reduce the risk of stroke in patients with non‑valvular atrial fibrillation. As an API, it is primarily used in film‑coated tablets of different strengths.
Key Indications
- Prevention of stroke and systemic embolism in non‑valvular atrial fibrillation
- Treatment and secondary prevention of DVT and PE
- Prophylaxis of VTE following major orthopaedic surgery
Quality Considerations
Quality Rivaroxaban API should have tightly controlled impurity levels, particle size distribution, and polymorphic form. Robust analytical methods and ICH‑compliant stability studies are essential to support registration and long‑term supply.
Share this article:
About Vubrix Pharma Team
Our team of pharmacists and medical writers share accurate, easy-to-understand medicine information for healthcare professionals and patients.
Related Articles
Aripiprazole API: Uses, Pharmacology, and Quality Specifications
Learn about Aripiprazole active pharmaceutical ingredient (API) – indications, mechanism of action, typical finished dosage forms, and key quality parameters for reliable sourcing.
Fluconazole API: Antifungal Uses, Dosage Forms, and Quality Parameters
Discover key information about Fluconazole active pharmaceutical ingredient (API), including indications, mechanism of action, typical dosage forms, and quality expectations.
Aceclofenac API: NSAID Uses, Formulations, and Safety Highlights
Technical and clinical overview of Aceclofenac API, a widely used NSAID for pain and inflammation, including its mechanism, indications, and formulation considerations.